Labcorp Holdings, Inc. provides laboratory services that include clinical laboratory testing, drug development services, and genomic testing. Its customers include healthcare providers, hospitals, pharmaceutical companies, and patients. Revenue is generated primarily from clinical laboratory services (approximately 70%), drug development services (around 25%), and genomic testing (about 5%). Factors supporting endurance include the growing demand for healthcare services and advancements in medical technology. However, potential limitations include regulatory changes and competition from other laboratory service providers.
—
Labcorp Holdings, Inc. provides laboratory services that include clinical laboratory testing, drug development services, and genomic testing. Its customers include healthcare providers, hospitals, pharmaceutical companies, and patients. Revenue is generated primarily from clinical laboratory services (approximately 70%), drug development services (around 25%), and genomic testing (about 5%). Factors supporting endurance include the growing demand for healthcare services and advancements in medical technology. However, potential limitations include regulatory changes and competition from other laboratory service providers.
—
Daily adjusted close
Labcorp Holdings, Inc. provides laboratory services that include clinical laboratory testing, drug development services, and genomic testing. Its customers include healthcare providers, hospitals, pharmaceutical companies, and patients. Revenue is generated primarily from clinical laboratory services (approximately 70%), drug development services (around 25%), and genomic testing (about 5%). Factors supporting endurance include the growing demand for healthcare services and advancements in medical technology. However, potential limitations include regulatory changes and competition from other laboratory service providers.